View all text of Part 1321 [§ 1321.01 - § 1321.01]
§ 1321.01 - DEA mailing addresses.
The following table provides information regarding mailing addresses to be used when sending specified correspondence to the Drug Enforcement Administration.
Table of DEA Mailing Addresses
| Code of Federal Regulations Section—Topic | DEA mailing address | 1308.43(b)—Petition to initiate proceedings for rulemaking.
1316.23(b)—Petition for grant of confidentiality for research subjects. 1316.24(b)—Petition for exemption from prosecution for researchers. | Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, VA 22152. | 1307.03—Exception request filing.
1307.22—Delivery of surrendered and forfeited controlled substances. 1310.21(b)—Sale by Federal departments or agencies of chemicals which could be used to manufacture controlled substances certification request. 2 | Drug Enforcement Administration, Attn: Diversion Control Division/DC, 8701 Morrissette Drive, Springfield, VA 22152. | 1301.71(d)—Security system compliance review for controlled substances.
1309.71(c)—Security system compliance review for List I chemicals. 1310.03(c)—Mail-Order reports involving transactions with nonregulated persons or exports. 1 1310.05(b)(1)—Unusual or excessive loss or disappearance of listed chemicals. 1310.05(b)(2)—Reports of domestic regulated transactions in a tableting machine or an encapsulating machine. 1 1310.05(c)(1)—Reports of imports and exports of a tableting machine or an encapsulating machine. 1 1310.05(c)(2)—Report of declared exports of machines refused, rejected, or returned. 1312.12(a)—Application for import permit (DEA Form 357). 1 1312.18(b)—Import declaration (DEA Form 236) submission. 1 1312.22(g)(8)—Request for return of unacceptable or undeliverable exported controlled substances. 1 1312.27(a)—Controlled substances export declaration (DEA Form 236) filing. 1 1312.31(b)—Controlled substances transshipment permit application. 1312.32(a)—Advanced notice of importation for transshipment or transfer of controlled substances. 1313.12(b)—Authorization to import listed chemicals (DEA Form 486/486A). 1 1313.12(e)—Quarterly reports of listed chemicals importation. 1313.21(b)—Authorization to export listed chemicals (DEA Form 486). 1 1313.21(e)—Quarterly reports of listed chemicals exportation. 1313.22(c)—Notice of declared exports of listed chemicals refused, rejected or undeliverable. 1 1313.31(b)—Advanced notice of importation for transshipment or transfer of listed chemicals. 1313.32(b)(1)—International transaction authorization (DEA Form 486). 1 1314.110(a)(1)—Reports for mail-order sales. 1314.110(a)(2)—Request to submit mail-order sales reports. | Drug Enforcement Administration, Attn: Regulatory Section/DRG, 8701 Morrissette Drive, Springfield, VA 22152. | 1308.21(a)—Exclusion of nonnarcotic substance.
1308.23(b)—Exemption for chemical preparations. 1308.24(d)—Exempt narcotic chemical preparations importer/exporter reporting. 1308.24(i)—Exempted chemical preparations listing. 1308.25(a)—Exclusion of veterinary anabolic steroid implant product application. 1308.26(a)—Excluded veterinary anabolic steroid implant products listing. 1308.31(a)—Exemption of a nonnarcotic prescription product application. 1308.32—Exempted prescription products listing. 1308.33(b)—Exemption of certain anabolic steroid products application. 1308.34—Exempted anabolic steroid products listing. 1310.13(b)—Exemption for chemical preparations. 1310.05(d)—Bulk manufacturer of listed chemicals reporting. | Drug Enforcement Administration, Attn: Drug & Chemical Evaluation Section/DRE, 8701 Morrissette Drive, Springfield, VA 22152. | 1303.12(b)—Application for controlled substances procurement quota (DEA Form 250) filing and request. | Drug Enforcement Administration, Attn: UN Reporting & Quota Section/DRQ, 8701 Morrissette Drive, Springfield, VA 22152. | 1303.12(d)—Controlled substances quota adjustment request.
1303.22—Application for individual manufacturing quota (DEA Form 189) filing and request for schedule I or II controlled substances. 1304.31(a)—Manufacturers importing narcotic raw material report submission. 1304.32(a)—Manufacturers importing coca leaves report submission. 1315.22—Application for individual manufacturing quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 189) filing and request. 1315.32(e)—Application for procurement quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 250) filing and request. 1315.32(g)—Procurement quota adjustment request for ephedrine, pseudoephedrine, and phenylpropanolamine. 1315.34(d)—Application for import quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 488) request and filing. | 1315.36(b)—Request import quota increase for ephedrine, pseudoephedrine, or phenylpropanolamine. | 1304.04(d)—ARCOS separate central reporting identifier request.
1304.33(a)—Reports to ARCOS. | Drug Enforcement Administration, Attn: ARCOS Unit/DOPT, P.O. Box 2520, Springfield, VA 22152-2520 OR Drug Enforcement Administration, Attn: ARCOS Unit, 8701 Morrissette Drive, Springfield, VA 22152. | 1301.03—Procedures information request (controlled substances registration) | Drug Enforcement Administration, Attn: Registration Section/DRR P.O. Box 2639, Springfield, VA 22152.
1301.13(e)(2)—Request DEA Forms 224, 225, and 363. 1301.14(a)—Controlled substances registration application submission. 1301.18(c)—Research project controlled substance increase request. 1301.51—Controlled substances registration modification request. 1301.52(b)—Controlled substances registration transfer request. 1301.52(c)—Controlled substances registration discontinuance of business activities notification. 1309.03—List I chemicals registration procedures information request. 1309.33(a)—List I chemicals registration application submission. | 1309.61—List I chemicals registration modification request | 1301.43—Request for hearing or appearance; waiver.
1303.34—Request for hearing or appearance; waiver. 1308.44—Request for hearing or appearance; waiver. 1316.45—Hearings documentation filing. 1316.46(a)—Inspection of record. 1316.47(a)—Request for hearing. 1316.48—Notice of appearance. | Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, VA 22152. | 1301.33(a)—Filing of written comments regarding application for bulk manufacture of Schedule I and II substances.
2 1301.34(a)—Filing of written comments regarding application for importation of Schedule I and II substances. 2 1303.11(c)—Filing of written comments regarding notice of an aggregate production quota. 2 1303.13(c)—Filing of written comments regarding adjustments of aggregate production quotas. 2 1303.13(c)—Filing of written comments regarding adjustments of aggregate production quotas. 2 1308.43(g)—Filing of written comments regarding initiation of proceedings for rulemaking. 2 | Drug Enforcement Administration, Attn: Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, VA 22152.
|
|---|
1 Applications/filings/reports are required to be filed electronically in accordance with this chapter.
2 Applications/filings/reports may be filed electronically in accordance with this chapter.